Ken Harris

Abbott (United States)

Papers

1

Total Citations

158

H-Index

1

About

Ken Harris is a pioneering figure in clinical laboratory automation, best known for his instrumental role in developing the Abbott IMx system, a landmark benchtop immunochemistry analyzer that revolutionized diagnostic testing. His core research centers on immunoassay technology and automated clinical instrumentation, with a particular focus on making complex biochemical analyses accessible for routine hospital labs. Harris’s most significant contribution is the invention of the Microparticle capture Enzyme ImmunoAssay (MEIA), a novel technology that enabled rapid, reliable measurement of high-molecular-mass analytes. This breakthrough, detailed in his highly cited 1988 paper (158 citations), combined with fluorescence polarization immunoassay capabilities, allowed the IMx to perform a wide range of tests—from hormones to infectious disease markers—with unprecedented speed and precision. The system became a global standard in clinical chemistry, dramatically improving workflow and patient turnaround times. Harris’s work not only advanced laboratory medicine but also set the foundation for modern point-of-care diagnostics, demonstrating how thoughtful engineering can bridge the gap between complex biochemistry and everyday clinical practice.

Research Focus

Key Achievements

1
H-Index
1
Papers
158
Total Citations
158
Avg Citations/Paper
🏆 Most Cited Paper
The Abbott IMx automated benchtop immunochemistry analyzer system.
158 citations · 1988
📈 Most Prolific Year: 1988 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Abbott (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago